Details of the Drug Reposition

General Information of This Drug (ID: DM4PRFC)

• Drug Name: Bupivacaine (DM4PRFC)
• Synonyms: Anekain; Bloqueina; Bucaine; Bupivacaina; Bupivacainum; Bupivan; CBupivacaine; Carbostesin; DepoBupivacaine; Marcaina; Marcaine; Sensorcaine; Bupivacaine Carbonate; Bupivacaine HCL; Bupivacaine HCL KIT; Marcaine HCL; Marcaine Spinal; AH 250; Win 11318; Win 11318 HCl; Bucaine (TN); Bupivacaina [INN-Spanish]; Bupivacaine (INN); Bupivacaine Monohydrochloride, Monohydrate; Bupivacaine [INN:BAN]; Bupivacainum [INN-Latin]; DL-Bupivacaine; DUR-843; Marcain (TN); Marcaine (TN); Sensorcaine (TN); Sensorcaine-MPF; Sensorcaine-MPFSpinal; Transdur-Bupivacaine; Vivacaine (TN); Dl-1-Butyl-2',6'-pipecoloxylidide; (1)-1-Butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide; (inverted exclamation markA)-bupivacaine; 1-Butyl-2',6'-pipecoloxylidide; 1-Butyl-N-(2,6-dimethylphenyl)-2-piperidinecarboxamide; 1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide
• Therapeutic Class: Anesthetics
• Drug Type: Small molecular drug

Information on Drug Reposition of This Drug

3 Approved Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Anaesthesia	DIS5D4R1	9A78.6	Approved	[1]
Periodontitis	DISI9JOI	DA0C	Approved	[2]
Articular cartilage disorder	DIS9LQVD	FA34.Y	Approved	[2]

1 Phase 2 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Pain	DIS4RWOW	MG30-MG3Z	Phase 2	[3]

2 Investigative Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Pruritus	DISVH62W	EC90	Investigative	[2]
Chronic pain	DISXRS8Y	MG30	Investigative	[2]

References

• [1] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2397).
• [2] Bupivacaine FDA Label
• [3] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)